The global thyroid gland disorder treatment market size is
expected to reach USD 2.6 billion by 2025, according to a new report by Grand
View Research, Inc., and exhibit a 3.2% CAGR during the forecast period.
Increase in prevalence of thyroid diseases around the globe is expected to
drive demand for anti-thyroid drugs in the coming years. Hypothyroidism is one
of the leading causes of hospitalization in U.S. Growing awareness about
disease management amongst healthcare professionals and patients is another
factor augmenting market growth. There are various private and public
organizations working toward spreading awareness related to disease management,
such as British Thyroid Foundation,The American Thyroid Association (ATA),
and Thyroid Foundation of Canada.
Rising demand for these drugs has resulted in
development of various generic equivalents of branded drugs to treat thyroid
gland disorders. Generic drug manufacturers are focusing on strategies such as
new product development, distribution channel enhancement, regional expansions,
and collaborations with other companies for marketing their products to gain an
edge over the competition. In addition, regulatory authorities that approve
generic versions of branded drugs are working to overcome delays in product
approvals and enable the availability of these drugs at a lower price. This is
expected to boost the market over the forecast period.
Browse full research report on Thyroid
Gland Disorder Treatment Market: https://www.grandviewresearch.com/industry-analysis/thyroid-gland-disorder-treatment-market
Further key
findings from the report suggest:
- Hypothyroidism held the dominant revenue share
in 2016 and is expected to maintain its position throughout the forecast
period. On the other hand, hyperthyroidism is expected to witness steady
growth on account of increase in incidence of Graves’ disease
- The oral route is the most preferred or most
frequently used route of administration owing to its convenience and
simplicity, which helps improve patient compliance. The market is driven
by the presence of a strong pipeline of oral anti-thyroid medications
- Wholesalers accounted for the largest revenue
share as of 2016 owing to increasing spending on outpatient prescription
drugs along with overall healthcare expenditure. E-commerce is expected to
witness lucrative growth in the coming years
- The U.S. thyroid gland disorder treatment
market is anticipated to exceed USD 1.03 billion by 2025 due to presence
of sophisticated healthcare infrastructure, increased patient awareness,
and high healthcare expenditure and R&D in drug discovery and
development
- Asian countries, especially India and China,
are expected to observe remarkable growth in the coming years
- The market is fragmented in nature, with
presence of various large and small pharmaceutical players
- Some of the key companies in the market
areAbbott; AbbVie, Inc.; Merck KGaA; Mylan N.V.; Amgen Inc.; Pfizer, Inc.;
GlaxoSmithKline plc.; and Lannett Company, Inc.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/thyroid-gland-disorder-treatment-market/request/rs1
Grand
View Research has segmented the global thyroid gland disorder treatment market
on the basis of indication, route of administration, distribution channel, and
region:
Thyroid Gland
Disorder Treatment Indication Outlook (Revenue, USD Million, 2014 - 2025)
- Hypothyroidism
- Hyperthyroidism
Thyroid Gland
Disorder Treatment Route of Administration Outlook (Revenue, USD Million, 2014
- 2025)
- Oral
- Intravenous
- Others
Thyroid Gland
Disorder Treatment Distribution Channel Outlook (Revenue, USD Million, 2014 -
2025)
- Wholesalers/Distributors
- Retail Chain
- Online Distribution
- Others
Thyroid Gland
Disorder Treatment Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East &
Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment